Showing results (6581-6590 of 37,639) with videos related to
Sort By:
Pageof 3,764
Cancers|December 17, 2024
Beyond Obstruction: Evaluating Self-Expandable Metallic Stents (SEMSs) vs. Emergency Surgery for Challenging pT4 Obstructive Colon Cancer: Multicentre Retrospective StudyMarta Paniagua García-Señoráns, Carlos Cerdán-Santacruz, Oscar Cano-Valderrama, et al.Cancers|December 17, 2024
Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase TrialsMarianne Zoghbi, Brina A Patel, Matthieu Roulleaux Dugage, et al.Cancers|December 17, 2024
Pre-Surgical Endoscopic Biopsies Are Representative of Esophageal and Esophago-Gastric Junction Adenocarcinoma Histologic Classes and Survival RiskAlessandro Gambella, Roberto Fiocca, Marialuisa Lugaresi, et al.Cancers|December 17, 2024
Discovery, Validation and Mechanistic Study of XPO1 Inhibition in the Treatment of Triple-Negative Breast CancerAmy L Paulson, Robert F Gruener, Adam M Lee, et al.Cancers|December 17, 2024
Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell SequencingSaleh Alrhmoun, Marina Fisher, Julia Lopatnikova, et al.Cancers|December 17, 2024
Unraveling the Genetic Heterogeneity of Acute Lymphoblastic Leukemia Based on NGS ApplicationsValentina Ramírez Maldonado, Josgrey Navas Acosta, Iván Maldonado Marcos, et al.Cancers|December 17, 2024
Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?Gabriele Giuseppe Pagliari, Francesca Colonese, Stefania Canova, et al.Cancers|December 17, 2024
Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry StudyRobert C G Martin, Rebekah Ruth White, Malcolm M Bilimoria, et al.Cancers|December 17, 2024
The Synergy of Thermal and Non-Thermal Effects in Hyperthermic OncologyCarrie Anne Minnaar, Gyula Peter Szigeti, Andras SzaszCancers|December 17, 2024
Reply to Itagaki et al. Comment on "Dorobisz et al. Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site. Cancers 2024, 16, 3416"Karolina Dorobisz, Tadeusz Dorobisz, Katarzyna Pazdro-ZastawnyPageof 3,764